Advertisement
Loading...

Basilea Pharmaceutica AG

BPMUFPNK
Healthcare
Biotechnology
$65.10
$0.00(0.00%)
U.S. Market opens in 7h 15m

Basilea Pharmaceutica AG (BPMUF) Stock Competitors & Peer Comparison

See (BPMUF) competitors and their performances in Stock Market.

Peer Comparison Table: Biotechnology Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BPMUF$65.10+0.00%805.6M9.14$7.12N/A
NONOF$43.80-0.64%197.7B10.45$4.26+4.05%
CSLLY$17.69-0.90%68.3B11.46$1.54+4.09%
UCBJY$140.35-0.41%53.4B29.95$4.68+0.60%
UCBJF$270.35-4.22%51.5B29.29$9.23+0.60%
ARGNF$803.19+0.00%49.7B35.71$22.49N/A
CMXHF$70.00-4.83%34.3B11.60$6.17+3.97%
IVBXF$10.34+0.39%17.9B147.71$0.07N/A
WXIBF$4.18+0.00%17.3B24.59$0.17N/A
WXXWY$8.29-1.78%17.1B24.32$0.34N/A
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BPMUF vs NONOF Comparison May 2026

BPMUF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BPMUF stands at 805.6M. In comparison, NONOF has a market cap of 197.7B. Regarding current trading prices, BPMUF is priced at $65.10, while NONOF trades at $43.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BPMUF currently has a P/E ratio of 9.14, whereas NONOF's P/E ratio is 10.45. In terms of profitability, BPMUF's ROE is +0.35%, compared to NONOF's ROE of +0.66%. Regarding short-term risk, BPMUF is less volatile compared to NONOF. This indicates potentially lower risk in terms of short-term price fluctuations for BPMUF.Check NONOF's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions